Efficacy and Safety of Low-Dose Rivaroxaban Added to Dual Antiplatelet Therapy for the Prevention of Left Ventricular Thrombus Following High-Risk ST-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials